Клиническое значение жидкостной цитологии в диагностике заболеваний шейки матки
Диссертация
Так, по данным зарубежной литературы, новая методика приготовления стандартизированных цитологических микропрепаратов — жидкостная цитология — является наиболее перспективной для диагностики патологии шейки матки, в том числе и как скрининговая, хотя мнение различных исследователей о целесообразности использования нового метода неоднозначно (35, 43, 45, 52, 108, 145, 149). Считается, что… Читать ещё >
Содержание
- Список сокращений
- Глава 1. Литературный обзор
- 1. 1. Заболеваемость раком шейки матки
- 1. 2. Методы диагностики (скрининга) заболеваний шейки матки
- 1. 3. Классификация и терминология, используемые в диагностике заболеваний шейки матки
- 1. 4. Роль цитологического скрининга в выявлении предрака и рака шейки матки
- 1. 5. Жидкостная цитология — новая перспективная технология цитологической диагностики заболеваний шейки матки
- Глава 2. Объект, протоколы и методы исследования
- 2. 1. Объект исследования
- 2. 2. Протоколы исследования
- 2. 3. Методы исследования
- 2. 3. 1. Клиническое обследование
- 2. 3. 2. Цитологические методы
- 2. 3. 3. Кольпоскопическое исследование
- 2. 3. 4. Гистологическое исследование
- 2. 3. 5. Методы статистического анализа
- 4. 1. Анализ эффективности традиционного цитологического метода исследования в диагностике заболеваний шейки матки
- 4. 2. Анализ эффективности жидкостной цитологии в диагностике заболеваний шейки матки
- 4. 3. Сравнительный анализ эффективности традиционной и жидкостной цитологии в диагностике заболеваний шейки матки (протокол № 1)
- 4. 4. Сравнительный анализ эффективности традиционной и жидкостной цитологии в диагностике заболеваний шейки матки (протокол № 2)
- 4. 5. Возможности жидкостной цитологии в диагностике вагинальных инфекций
Список литературы
- Агикова JI.A. Рациональная иммунокорригирующая терапия гликопином у больных с папилломавирусной инфекцией шейки матки // Дис.к.м.н.- Москва, 1996. 162 с.
- Волков В. Г. Система профилактики и ранней диагностики предраковых заболеваний / Дис. д.м.н. — Москва, 2002. 215 с.
- Казаченко В.П. Рак шейки матки // Современная онкология. 2000. — т. 2. — № 2.
- Колеман Д. Контроль качества в скрининге рака шейки матки // Клиническая лабораторная диагностика. 1995. — № 5. — С. 99−101.
- Коновалов О.Е., Баев М. В. Состояние и проблемы активного выявления больных заболеваниями, передаваемыми половым путем // Здравоохранение Российской Федерации. Медицина. — 1999. — № 2. — С. 47 — 49.
- Королев B.C., Горбунов В .Я., Слюсарь Н. Н. Особенности заболеваемости и смертности женщин трудоспособного возраста от рака шейки матки // Здравоохранение Российской Федерации. -1999. № 1. — С. 29−30.
- Краевский Н.А., Смольянников А. В., Саркисов Д. С. Патологоанатомическая диагностика опухолей человека. Руководство для врачей. В двух томах. Москва: Медицина, 1993.
- Кулаков В.И., Тохман А. А. Проблемы злокачественных образований репродуктивной системы в практике гинеколога // Онкологический скрининг, канцерогенез и ранние стадии рака в практике гинеколога: Сб. науч. трудов. -Ижевск, 2000.-С 8−11.
- Минкина Г. Н. Плоскоклеточные интраэпителиальные поражения // Дис. д. м. н. Москва, 1999. — с. 39.
- Минкина Г. Н., Манухин И. Б., Франк Г. А. Предрак шейки матки. -Москва: Аэрограф-медиа, 2001. 112 с.
- Новик В.И. Проблемы цитологического скрининга рака шейки матки // Новости клинической цитологии России. 2001. — т. 5. — № 1 — 2. — С. 93.
- Олийниченко П.И., Собко Н. П. Цитологический скрининг рака шейки матки в Киеве и вопросы его совершенствования // Лабораторная диагностика. 2000. — № 2. — С. 48−52.
- Петрова А.С., Агамова К. А., Ермолаева А. Г. Роль и место цитологической диагностики в клинической практике // Клиническая лабораторная диагностика. 1994. — № 4. — С. 4−7.
- Петрова Г. В. Показатели онкологической помощи больным раком шейки матки в России // Российский онкологический журнал. 2003. — № 5. — С. 36−38.
- Прилепская В.Н. Заболевания шейки матки, влагалища и вульвы. -Москва: «МЕДпресс», 2000. 432 с.
- Прилепская В.Н., Кондриков Н. И., Бебнева Т. Н. Значение вирусов папилломы человека в развитии диспластических процессов шейки матки // Гинекология. 2000. — т. 2. — № 3.
- Прилепская В.Н., Кондриков Н. И., Бебнева Т. Н. Патология шейки матки. Диагностические возможности цитологического метода исследования // Акушерство и гинекология. 1999. -№ 6. — С. 45−49.
- Русакевич П.С. Заболевания шейки матки. Минск: Вышэйшая школа, 2000.-368 с.
- Соловьев В.И., Новикова Р. И., Большакова Г. А. Цитологический скрининг женского населения Смоленской области по данным проведения профилактических осмотров за 5 лет // Клиническая лабораторная диагностика. М. — 1998. — № 9. — С 48.
- Трапезников Н.Н., Аксель Е. М. Онкологическая заболеваемость и смертность населения России и стран СНГ в 1998 г. — Москва, 2000.
- Урманчеева А.Ф., Мерабишвили В. М., Сельков С. А. и соавтор. Эпидемиология и диагностика рака шейки матки // Журн. акушерства и женских болезней. 2001. — № 1. — С. 80−86.
- Флетчер Р., Флетчер С., Вагнер Э. Клиническая эпидемиология. Основы доказательной медицины. Москва: Медиа Сфера, 1998. — 352 с.
- Хмельницкий O.K. Цитологическая и гистологическая диагностика заболеваний шейки и тела матки. Санкт-Петербург: Сотис, 2000. — 333 с.
- Черенков В.Г., Локтионова М. А., Иванченко О. Г., Субботина О. Ю. Готовы ли мы к угрозе онкогенной папилломовирусной инфекции и эффективному цитологическому скринингу // Новости клинической цитологии России. -2001. т. 5. — № 1 — 2. — С. 110−112.
- Чиссов В.И., Старинский В. В., Петрова Г. В. и соавтор. Основные показатели онкологической помощи населению в 2000 г. // Российский окологический журнал. 2002. — № 1. — С. 35−39.
- Чиссов В.И., Старинский В. И., Петрова Г. В. Состояние онкологической помощи населению России в 2001 году. — Москва, 2002.
- Шабалова И.П. Интерактивные программы и молекулярные исследования для оптимизации цитологической диагностики // Дис.д.м.н. — Москва, 2002.-227 с.
- Шабалова И.П. Цитологический атлас. Критерии диагностики заболеваний шейки матки. — Москва, 2001. С. 5−9.
- Abulafia О., Pezzullo J.C., Shere D.V. Performance of ThinPrep liquid-based cervical cytology in comparison with conventionally prepared Papanicolaou smears: a quantitative survey // Gynecologic Oncology. 2003. — Vol. 90. — № 1. — P. 137−144.
- Allen S.M. Cervical intraepithelial neoplasia: false negative smears // Brit. J. Biomedical Science. 1998. — Vol. 53. — № 2. — P. 152−156
- Anagnostopoulou I., Rammou-Kinia R. Human papilloma virus DNA screening and typing on cervical smears by non-isotopic in situ Hybridization // Cytopathology. 1998. — Vol. 9. — № 1. — P. 35.
- Andy C., Turner L.F., Neher J.O. Is the ThinPrep better than conventional Pap smear at detecting cervical cancer? // J. Fam. Pract. 2004. — Vol. 53. — № 4. -P. 313−315.
- Anttila A., Ronco G., Clifford G. et al. Cervical cancer screening programmers and policies in 18 European countries // Br J Cancer 2004. — Vol. -91. — № 5. — P. 935−941.
- Autillo-Teuati A., Joannes M., d" Ercole C. et al. HPV-typing by in situ hybridization on cervical cytologic smears with ASCUS // Acta Cytologica. -1998. Vol. 42. — № 3. — P. 631−639.
- Baer A., Kiviat N.B., Kulasingam S et al. Liquid-based Papanicolaou smears without a transformation zone component: should clinicians worry // Obstetrics and Gynecology. 2002. — Vol. 99. — № 6. — P. 1053−1059.
- Baker JJ. Conventional and liquid-based cervicovaginal cytology: a comparison study with clinical and histologic follow-up // Diagn. Cytopathol. -2002.-Vol. 27.-№ 3.-P. 185−188.
- Baldauf J.J., Dreyfus M., Ritter J. et al. Screening histories of incidence cases of cervical cancer and high grade SIL. A comparison // Acta Cytol. 1997. -Vol. 41. -№ 5. -p. 1431−1438
- Ball C., Madden J.E. Update cervical cancer screening // Postgraduate Medicine. 2003. — Vol. 113. — № 2. — P. 59−70.
- Belinson J.L., Pan Q.J., Biscotti C. Primary screening with liquid-based cytology in an unscreened population in rural China, with an emphasis on reprocessing unsatisfactory samples // Acta Cytol. 2002. — Vol 46. — № 3. — P 470 474.
- Bergeron C., Bishop J., Lemarie A. et al. Accuracy of thin-layer cytology in patients undergoing cervical cone biopsy // Acta Cytol. 2001. — Vol 45. — P 519 524.
- Bergeron C., Jeannel D., Poveda J. et al. Human papillomavirus testing in women with mild cytologic atypia // Obstet. Gynecol. 2000. — Vol. 95. — P. 821 827.
- Bibbo M., Klump W.J., DeCecco J. Procedure for immunocytochemical detection of P16INK4A antigen in thin-layer, liquid-based specimens // Acta Cytol. 2002. — Vol 46. — № 1. — P 25−29.
- Bishop J.W., Bigner S.H., Colgan T.J. et al. Multicenter masked evaluation of AutoCyte prep, thin-layers with matched conventional smears — including initial biopsy results // Acta Cytol. 1998. — Vol 42. — P 189−197.
- Blumenthal P.D. Adjunctive testing for cervical cancer in low resource setting with visual inspection, HPV and Pap smear // Am. J. Obstet. Gynecol. -2001.-Vol. 72.-P. 47−53.
- Boss A.B., van Ballegooijen M., van den Аккег-van Marie M.E. et al. Endocervical status is not predictive of the incidence of cervical cancer in the years after negative smears // Am. J. Clin. Pathol. 2001 — Vol 115. — P. 851−855.
- Broadstock M. Effectiveness and cost-effectiveness of automated and semi-automated cervical screening devices: a systematic review // NZHTA Report. -2000.-Vol.3.-P. 1−130.
- Buntinx F., Arbyn M. Conventional cervical smears were better than monolayer cytology or human papillomavirus testing for detecting cervical cancer // Evid. Based Med. 2003. — Vol 8. — P. 187.
- Carozzi F., Noferini D., Confortini M. et al. The value of HPV testing in predicting the development of high grade lesions: a case control study, 27-th European Congress of Cytology // Cytopathology. 2000. — Vol. 11. — № 5. — P. 367−368.
- Chacho M.S., Mattie M.E., Schwartz P.E. Cytohistologic correlation rates between conventional Papanicolaou smears and ThinPrep cervical cytology: a comparison // Cancer 2003. — Vol. 99. — № 3. — P. 135−140.
- Chhieng D.C., Talley L.I., Roberson J. Interobserver variability: comparison between liquid-based and conventional preparations in gynecologic cytology // Cancer 2002. — Vol. 96. — № 2. — P. 67−73.
- Clavel C., Masure M., Bory J. et al. Human papillomavirus testing for primary screening for the detection of high-grade cervical lesions: a study of 7932 women // Br. J. Cancer. 2001. — Vol 84. — P. l 616−1623.
- Cochand-Priollet В., Le Gales C., de Cremoux P. et al. Cost-effectiveness of monolayers and human papillomavirus testing compared to that of conventional
- Papanicolaou smears for cervical cancer screening: protocol of the study of the French Society of Clinical Cytology // Diagn. Cytopathol. 2001. — Vol. 24. — P 412−420.
- Corkhill M., Knapp D., Hutchinson M.L. Imrpoved accuracy of cervical cytology with the thin-prep method and the endocervical brush-spatula collection procedure // J. Lower Genital Tract Dis. 1998. — Vol. 2. — P. 12−16.
- Coste J., Cochand-Priollet В., de Cremoux P. et al. Cross sectional study of conventional cervical smear, monolayer cytology and human papillomavirus DNA testing for cervical cancer screening // BMJ. 2003. — Vol. 326. — P. 733−736.
- Cox J.T. Management atypical squamous cells of undetermined significance and low-grade squamous intraepithelial lesion by human papillomavirus testing // Clin. Obstetr. Gynaecol. 2001. — Vol 15. — P. 715−741.
- Critchlow C.W., Koutsky L.A. Epidemiology of human papillomavirus infection. In: Mindel A., editor. Genital warts. Human papillomavirus infection. London. Edward Arnold. 1995. -P. 53−81.
- Cuzick J. Human papillomavirus testing for primary cervical cancer screening Editorial. // JAMA. 2000. — Vol. 283. — P. 108 — 109.
- Cuzick J., Beverley E. Ho L., Terry G. et al. HPV testing in primary screening of older women // B. J. Cancer. 1999. — Vol 81. — P. 554 — 558.
- Dalton L.W., Page D.L., Dupont W.D. Histologic grading of breast carcinoma. A reproducibility study // Cancer 2002. — Vol. 73. — P. 2726−2770.
- Davey D.D. Cervical cytology classification and the Bethesda System // Cancer J. 2003. — Vol. 9. — № 5. — P. 327−334.
- Davison J.M., Marty J.J. Detecting premalignant cervical lesions. Contributions of screening colposcopy to cytology // J. Reprod. Med. 1994. — № 39.-P. 388−392.
- Denny L., Kuhn L., Risi L. et al. Two-stage cervical cancer screening: an alternative for resource-poor settings // Am. J. Obstet. Gynecol. — 2000. — Vol. 183.-P. 383−388.
- Detweiler R., Castilleja R., Sneige N. Endocervical columnar cells and adequacy of cervical sampling: analysis of 43 discordant smears and cervical biopsies //Acta Cytol. 1989. — Vol. 33. — P. 730−731.
- Dhurandahar N.R., Sullivan D., Rai J., Degefu S. Utility of HPV-DNA detection in the management of women with cytologic abnormalities on Papanicolaou smears // Acta Cytologica. 1994. — Vol. 38. — № 5. — P. 809.
- Dillner J. Trends over time in the incidence of cervical neoplasia in comparison to trends over time in human papillomavirus infection // Clin. Virol. -2000.-Vol. 19.-P. 7−23.
- Dupree W.B., Suprun H.Z., Beckwith D.G. et al. The promise and risk of new technology. The Lehing Valley Hospitals experience with liquid-based cytology // Cancer. 1998. — № 84. — P. 202−207.
- Ellerbrock T.V., Chiasson M.A., Bush T.J. et al. Incidence of cervical squamous intraepithelial lesions in HPV-infected women // JAMA. 2000. — Vol. 283. — P.1031−1037.
- Enomoto Т., Haba Т., Fujita M. et al. Clonal analysis of high-grade squamous intraepithelial lesions of the uterine cervix // Inter. J. Cancer. — 1997. -Vol.-73.-P. 339−344.
- EUROGIN and the WHO, 1996 Cervical cancer control: general statements and guidelines // Genital infections and neoplasia. 1998. — Vol. — 1. — № 6. — P. 20−22.
- Fahey M.T., Irwig I., Macascill P. Meta-analysis of PAP-test accuracy // Am. J. Epidemiol. 1995. — Vol. 142. — P. 680−689.
- Ferenczy A. Cervical intraepithelial neoplasia in women infected with human immunodeficiency virus: prevalence, risk factors, and validity of PAP smears // Genital infections and Neoplasia. 1998. — Vol. 1. — P. 24−25.
- Ferenczy A., Franco E. Persistent human papillomavirus infection and cervical neoplasia // Lancet Oncol. 2002. — Vol. 1. — P. 11−16.
- Franco E.L., Villa L.L., Richardson H. et al. Epidemiology of cervical human papillomavirus infection. In: Franco E. & Mosonego J., editors. New Developments in Cervical Cancer Screening and prevention. Oxford: Blackwell Science. -1997.-P. 14−22.
- Frega A., Stentella P., De Ioris A. et al. Young women, cervical intraepithelial neoplasia and human papillomavirus: risk factors for persistence and recurrence // Cancer Lett. 2003. — Vol. 196. — № 2. — P. 127−134.
- Freitas C., Milanezi F., Dias A.J. et al. Use of cell block preparation for morphological, immunocytochemistry and ploidy analysis in ThinPrep monolayer preparations // Diagn. Cytopathol. 2001. — Vol. 24. — № 2. — P. 142−144.
- Ghaemmaghami F., Behtash N., Modares Gilani M. et al. Visual inspection with acetic acid as a feasible screening test for cervical neoplasia in Iran // Int. J. Gynecol. Cancer. 2004. — Vol. 14. — № 3. — P. 465−469.
- Goldie S.J., Kim J.J., Wright T.C. Cost-effectiveness of human papillomavirus DNA testing for cervical cancer screening in women aged 30 years or more // Obstet. Gynecol. 2004. — Vol. 103. — P. 619−631.
- Goodman A. Role of human papillomavirus subtyping in cervical screening // Curr. Opin. Obstet. Gynecol. 2000. — Vol. 12. — P. 11−14.
- Grace A., McBrearty P., Troost S. et al. Comparative study: conventional cervical and ThinPrep Pap tests in a routine clinical setting // Cytopathology. — 2002. Vol. 13. — № 4. — P. 200−205.
- Grace A., McBrearty P., Troost S. Performance of monolayered cervical smears in a gynecology outpatient setting in Kuwait // Acta Cytol. 2002. — Vol 46.-№ 2.-P 303−310.
- Guidos В J., Selvaggi S.M. Use of the Thin Prep Pap Test in clinical practice // Diagn. Cytopathol. 1999. — Vol. 20. — P. 70−73.
- Harkness C.B., Theofrastous J.P., Ibrahim S.N. et al. Papanicolaou and thin-layer cervical cytology with colposcopic biopsy control. A comparison // J. Reprod. Med. 2003. — Vol. 48. — № 9. -P. 681 — 686.
- Hartman K.E., Nanda K., Hall S. et al. Technologic advances for evaluation of cervical cytology: is newer better? // Obstet. Gynecol. Surv. 2001. — Vol 56. -№ 12. — P 756−774.
- Hecht J.L., Sheets E.E., Lee K.R. Atypical glandular cells of undetermined significance in conventional cervical/vaginal smears and thin-layer preparations // Cancer 2002. — Vol. 96. — № 1. — P. 1−4.
- Herbert A. Cervical screening: how often should women be screened? // Cytopathology. 2000. — № 11. — P. 75 — 81.
- Herbert A., Johnson J. Personal view. Is it reality or an illusion that liquid-based cytology is better than conventional cervical smears? // Cytopathology. -2001.-Vol. 12.-№ 6.-P. 383−389.
- Herzog T.J. New approaches for the management of cervical cancer // Gynecol. Oncol. 2003. — Vol. 90. — P. 22−27.
- Hesling J.J., Raso D.S., Schiffer B. Effectiveness of Thin-layer preparation vs. conventional Pap smears in a blinded split-sample study, extended cytological evaluation // J. Reprod. Med. 2001. — Vol. 46. — P. 880−886.
- Ho G.V., Bierman R., Beadsley L. et al. Natural history of cervico-vaginal papillomavirus infection in young women // N. Engl. J. Med. 1998. — Vol. 338. -№ 7.-P. 423−428.
- Hoerl H.D., Roth-Cline M.D., Shalkham J.E. et al. Rare atypical squamous cells of undetermined significance (ASCUS): a clinically significant diagnosis? // Diagn. Cytopathol. 2002. — Vol. 27. — № 1. — P. 5−9.
- Hutchinson M.L., Isenstein L.M., Goodman A. et al. Homogeneous sampling account for increased diagnostic accuracy using the Thin-Prep processor //Am. J. Pathol. 1994.-Vol. 101.-P. 215−219.
- Inhorn S.L., Wand P.J., Wright T.C. Chlamydia trachomatis and Pap testing from a single, fluid-based sample. A multicenter study // J. Reprod. Med. 2001. -Vol. 46. — № 3. — P. 237−242.
- Josefsson A. M. Viral load of human papilloma virus 16 as a determinant for development of cervical carcinoma in situ: a nested case-control study // Lancet. -2000.-Vol. 355. P. 2189−2193.
- Karwinski В., Tomic-Cica A., Lisaeth T. et al. Retrospective evaluation of the 5 year review of benign and LSIL cervical smears in women with HSIL, 27th European Congress of Cytology // Cytopathology. — 2000. — Vol. 11. — № 5. — P. 407 — 408.
- Kaufman R.H. Atypical squamous cells of undetermined significance and low-grade squamous intraepithelial lesion: diagnostic criteria and management // Am. J. Obstet Gynecol. 1996. — Vol. 175. — P. 1120−1128.
- Kaufmann R.H., Adam E. Is human papillomavirus testing of value in clinical practice? // Am. J. Obstet. Gynecol. 1999. — Vol. 180. — P. 1049−1053.
- Kim J.J., Wright T.C., Goldie S.J. Cost-effectiveness of alternative triage strategies for atypical squamous cells of undetermined significance // JAMA. -2002. Vol. 287. — P. 2382−2390.
- Kjaer S. К. Type specific persistence of high risk human papillomavirus (HPV) as indicator of high grade cervical squamous intraepithelial lesions in young women: population based prospective follow up study // BMJ. 2002. — Vol. 325. -P. 572.
- Klinkhamer P.J., Meerding W.J., Rosier P.F. et al. Liquid-based cervical cytology // Cancer 2003. — Vol. 99. — № 5. — P. 259−262.
- Knutsen E., Jenkin A., Majak В., Kristiansen B.E. Cytopathology of the cervix in relation to HPV typing by PCR // Cytopathology. 1998. — Vol. 9. — Ad. 1.-P.35.
- Kock K.F., Ejersbo D., Holund B. Follow-up of HPV changes in cervical smears // Cytopathology. 1998. — № 9 — Ad. 1. — P. 35.
- Koss L.G. Cervical (PAP) smear. New direction // Cancer. 1993. — Vol. 71 (Supple 4).-P. 1406−1412.
- Koss L.G. The Papanicolaou test for cervical cancer detection: triumph and tragedy JAMA. 1989. — Vol. 291. — P. 737−743.
- Koutsky L. Epidemiology of genital human papillomavirus infection // Am. J. Med. 1997. — Vol. 102. — № 5A. — P. 3−8.
- Krane J.F., Granter S.R., Trask C.E. et al. Papanicolaou smear sensitivity for the detection of adenocarcinoma of the cervix: a study of 49 cases // Cancer. -2001. Vol. 93. — № 1. — P. 8−15.
- Kristensen G., Skyggebjerg K.D., Holund B. et al. Analysis of cervical smears obtained within three years of the diagnosis of invasive cervical cancer // Acta Cytol. 1991. — Vol. 41. — P. 37−50.
- Kuhn L., Denney L., Pollack et al. Human papillomavirus DNA testing for cervical cancer screening in low-resource setting // J. Natl. Cancer Inst. — 2000. — Vol. 92.-P. 818−825.
- Kuhn L., Denny L., Pollack A. et al. HPV DNA testing for cervical cancer screening in low resource settings // J. Natl. Cancer Inst 2000. — Vol. 92. — P. 818−825.
- Kurtycz D.F., Hoerl D.H. Thin-layer technology: tempered enthusiasm // Diagn. Cytopathol. 2000. — Vol. 23. — P. 1−5.
- Laimins L.A. The biology of human papillomaviruses: from warts to cancer // Infect. Agents. Dis. 1993. — Vol 2. — P. 74 — 86.
- Landis S.M., Murray Т., Bolden S., Wingo P.A. Cancer statistics // CA Cancer J. Clin. 1998. — Vol 48. — P. 6−29.
- Lehman U., Poche-de Vos F., Poche-Blohm I. Detection of HPV DNA in Archival, Papanicolaou-Staind Cervical Smears Using PCR // Acta Cytologica. -1998. Vol. 42. — № 4. — P. 1051−1053.
- Limaye A., Connor A.J., Huang X., Luff R. Comparative analysis of conventional Papanicolaou test and fluid-based thin-layer method // Arch. Pathol. Lab. Med. 2003. — Vol. 127. — P. 200- 04.
- Linder J., Zahniser D. ThinPrep Papanicolaou testing to reduce false-negative cervical cytology // Arch Pathol Lab Med. 1998. — Vol 122. — № 2. — P. 139−144.
- Little J. Human papillomavirus testing. Effectiveness of testing for high risk HPV for triage of low grade abnormal smears is being assessed in TOMBOLA trial // BMJ. 2001. — Vol. 323. — P. 109.
- Lorincz A. T. Viral load of human papillomavirus and risk of CIN3 or cervical cancer // Lancet. 2002. — Vol. 360. — P. 228−229.
- Lorincz A.T., Reid R., Jenson A.B., Kurman R.T. Human papillomavirus infection of the cervix: relative risk associations of 15 common anogenital types // Obstet Gynecol. 1992. — Vol. 79. — P. 328 — 390.
- Maissi E., Marteau T.M., Hankins M. et al. Psychological impact of human papillomavirus testing in women with borderline or mildly dyskaryotic cervical smear test results: cross sectional questionnaire study // BMJ. 2004. — Vol. 29. -№ 328. — P. 1293.
- Malle D., Pateinakis P., Chakka E., Destouni C. Experience with a thin-layer, liquid-based cervical cytologic screening method // Acta. Cytol. 2003. -Vol. 47. — №. 2. — P. 129−134.
- Mandelblatt J.S. Costs and benefits of different strategies to screen in less-developed countries // J. Natl. Cancer Inst. 2002. — Vol. 94. — P. 1469−1483.
- Manos M.M., Kinney W.K., Hurley L.B. et al. Identifying women with cervical neoplasia. Using human papillomavirus DNA testing for equivocal Papanicolaou results // JAMA. 1999. — Vol. 281. — P. 1605−1610.
- Martin-Hirsch P.L., Koliopoulos G., Paraskevaidis E. Is it now time to evaluate the true accuracy of cervical cytology screening? // Eur. J. Gynaecol. Oncol. 2002. — Vol. 23. — № 4. — P. 363−365.
- Martin-Hirsch P.L., Lilford R., Jarvis G. et al. Efficacy of cervical-smear collection devices: a systematic review and meta-analysis // Lancet. — 1999. — Vol. 354.-P. 1763−1369.
- Massad L.S., Collins Y.C., Meyer P.M. Biopsy correlates of abnormal cervical cytology classified using The Bethesda System // Gynecol. Oncol. 2001. -Vol. 82.-P. 516−522.
- Matsuura Y., Kawagoe Т., Toki N et al. Low grade cervical intraepithelial neoplasia associated with human papillomavirus infection. Low-term follow-up // Acta Cytol. 1998. — Vol. 4. — P. 625−630.
- Mayney M., Eide D., Sotham J. Rates of condyloma and dysplasia in Papanicolaou smears with and without endocervical cells // Diagn. Cytopathology. -1990.- № 6. -P. 18−21.
- Michael C.W., Hunter B. Interpretation of five-needle aspirates processed by the ThinPrep technique: cytologic artifacts and diagnostic pitfalls // Diagn. Cytopathol. 2000. — Vol. 23. — P. 6−13.
- Milde-Langosch K., Riethdorf S., Loning T. Association of human papillomavirus infections with carcinoma of cervix uteri and its precursor lesions: theoretical and practical implications // Virchows Arch. 2000. — Vol. 437. — P. 227−233.
- Mitchell H., Medley G. Longitudinal study of women with negative cervical smears according to endocervical status // Lancet. 1991. — № 337. — P. 265−267.
- Monsonego J. Colposcopy: the value of HPV testing in clinical practice // Gynecol. Obstet. Fertil. 2004. — Vol. 32. — № 1. — P. 62−74.
- Monsonego J. Human papillomavirus screening realities and perspectives // Genital infections and Neoplasia. 1998. — Vol. 1. — № 6. — P. 7−10.
- Monsonego J., Autillo-Touati A., Bergeron C. et al. Liquid-based cytology for primary cervical cancer screening: a multi-centre study // Br. J. Cancer. 2001. — Vol. 84. — № 3. — P. 360−366.
- Montz F.J., Farber F.L., Bristow R.E. et al. Impact of increasing Papanicolaou test sensitivity and compliance: a modeled cost and outcomes analysis // Obstet Gynecol. 2001. — Vol. 97. — P. 781−788.
- Moseley R.P., Paget S. Liquid-based cytology: is this the way forward for cervical screening? // Cytopathology. 2002. — Vol. 13. — P. 71−82.
- Moss T.R. Cervical cytology and colposcopy in young patients attending genitourinary medicine clinics: invalid intrusion of preventive opportunity and definitive audit? // Cytopathology. 1999. — Vol. 10. — № 1. — P. 2−7.
- Nanda K., McCrory D.C., Myers E.R. et al. Accuracy of the Papanicolaou test in screening for and follow-up of cervical cytologic abnormalities: a systematic review It Ann. Intern. Med. 2000. — Vol. 132. — P. 810−819.
- Nobbenhius M.A., Walboomers J.M., Helmerhost T.J. et al. Relation of human papillomavirus status to cervical lesions and consequences for cervical cancer screening: progressive study // Lancet. — 1999. Vol. 354. — P. 20−25.
- Nold J.L. Cervical neoplasia. History screening — diagnosis — treatment // SD. J. Med. — 1998. — Vol. 51. — P. 113−119.
- Nuovo J., Melnikov J., Howell L. New tests for cervical cancer screening. // American Family Physician. 2001. — Vol. 64. — № 5. — P. 780−786.
- Nygard J.F., Sauer Т., Scare G.B., Thoresen S.Q. Follow-up of unsatisfactory and ASCUS/LSIL pap smears, 27-th European Congress of Cytology // Cytopathology. 2000. — Vol. 11. — № 5. — P. 426.
- Ozkan F., Ramzy I., Mody D.R. Glandular lesions of the cervix on thin-layer Pap tests. Validity of cytologic criteria used in identifying significant lesions // Acta Cytol. 2004. — Vol 48. — № 3. — P 372−379.
- Pan Q., Belinson J.L., Li L. et al. A thin-layer, liquid-based Pap test for mass screening in an area of China with a high incidence of cervical carcinoma. A cross-sectional, comparative study // Acta Cytol. 2003. — Vol 47. — № 1.. p 45−50.
- Paraskeviadis E., Malamou-Mitsi V., Koliopousol G. et al. Expanded Cytological referral criteria for colposcopy in cervical screening: comparison with human papillomavirus testing // Gynecologic Oncology. 2001. — Vol. 82. — P. 355−359.
- Park T.J., Richart R.M., Sun X-W. et al. Association between HPV type and clonal status of cervical squamous intraepithelial lesions (SIL) // J. Natl. Cancer Instit. 1996. — Vol. 88. — P 355−358.
- Parker E.M., Foti J.A., Wilbur D.C. FocalPoint slide classification algorithms show robust performance in classification of high-grade lesions on
- SurePath liquid-based cervical cytology slides // Diagn. Cvtopathol. 2004. — Vol. 30.-№ 2.- P. 107−110.
- Parker S.L., Davis K.J., Wingo P.A. et al. Cancer statistic by race and ethnicity // Ca Cancer J. Clin. 1998. — Vol. 48. — P. 31−48.
- Parkin D.M., Pisani P., Ferlay J. Estimates of worldwide incidence of eighteen major cancers in 1985 // Intern. J. Cancer. 1993. — Vol. 54. — P. 594 606.
- Peto J,. Gilham C., Deacon J. et al. Cervical HPV infection and neoplasia in a large population-based prospective study: the Manchester cohort // Br J Cancer. -2004. Vol. 91. — № 5. — P. 942−953.
- Ponten J., Adami H-O., Bergstrom R. et al. Strategies for global control of cervical cancer // Int. J. Cancer. 1995. — Vol. 60. — P. 1−26.
- Pragasam P.J., Rice D.K., Pierotti K. ASCUS Papanicolaou smears with HSIL biopsies: can they be predicated? // Acta Cytologica. — 1994. — Vol. 38. № 5.-P. 811.
- Quddus M.R., Sung С .J., Steinhoff M.M. et al. Atypical squamous jimetaplastic cells: reproducibility, outcome, and diagnostic features on ThinPrep Pap. test // Cancer. 2001. — Vol. 93. — № 1. — P. 16−22.
- Ratnam S., Franco E.L., Ferenczy A. Human papillomavirus testing for primary screening of cervical cancer precursors // Cancer Epidemiol. Biomarkers Prev. 2000. — Vol. 9. — P. 945−951.
- Reagan J.W., Fu Y.S. The uterine cervix // In: Silverberg S.G., editor. Principles and practice of surgical pathology. New York: Wiley, 1983. — Vol 2. -P. 1633 -1689.
- Reagan J.W., Seidemand I.L., Saracusa Y. The cellular morphology of carcinoma in situ and dysplasia or typical hyperplasia of the uterine cervix // Cancer. 1953. — Vol. 6. — P. 224 — 235.
- Report of Working Party set up by RCPath., BSCC and NHSCSP. Achievable standards, benchmarks for reporting and criteria for evaluating cervical // Cytopathology, 1995.
- Richart R.M. A sea change in diagnosing and managing HPV and cervical disease-part 1 // Am J. Obstet. Gynecol. 2002. Vol. 5. — P. 42−56.
- Richart R.M. Cervical intraepithelial neoplasia // Pathol. Ann. 1973. — Vol. 8.-P. 301 -328.
- Richart R.M. Natural history of cervical intraepithelial neoplasia // Clin. Obstet Gynecol. 1968. — Vol. 10. — P. 748 — 784.
- Richart R.M., Robles S., Wright T.C., Sankaranarayanan R. Cervical cancer screening strategies for developing countries // Am. J. Obstet. Gynecol. 2001. -Vol. 1.-P. 71−79- 100−117.
- Rinas A.S. The gynecological PAP test // Clin. Lab. Science. 1999. — Vol. 12.-P. 239−245.
- Ring M., Bolger N., OT) onnell M. et al. Evaluation of liquid-based cytology in cervical screening of high-risk populations: a split study of colposcopy and genito-urinary medicine populations // Cytopathology. 2002. — Vol. 13. — № 3. -P. 152−159.
- Roberson J., Connolly K., John K.S. Accuracy of reporting endocervical component adequacy a continuous quality improvement project // Diagn. Cytopathol. — 2002. — Vol. 27. — № 3. — P. 181−184.
- Sankaranarayanan R, Shyamalakumary B, Wesley R. et al. Visual inspection with acetic acid in the early detection of cervical cancer and precursors // Int. J. Cancer. 1999. — Vol. 80. — P. 161−163.
- Sankaranarayanan R., Black R.J., Parkin D.M. Cancer survival in developing countries // IARC. Scientific publication. — Lyon, 1998. — No. 145.
- Sankaranarayanan R., Wesley R., Somanathan T. et al. Performance of visual inspection after acetic acid application (VIA) in the detection of cervical cancer precursors // Cancer. 1998. — Vol. 83. — P. 2150−2156.
- Saslow D., Runowicz C., Solomon D. et al. American Cancer Society guideline for early detection of cervical neoplasia and cancer // CA Cancer J. Clinic. 2002. — Vol. 52. — № 6. — P. 342−362.
- Sass M.A. Use of a liquid-based, thin-layer Pap test in a community hospital. Impact on cytology performance and productivity // Acta Cytol. 2004. -Vol 48. — № L-P 17−22.
- Sawaya G. F., McConnell K. J., Kulasingam S. L. et al. Risk of cervical cancer associated with extending the interval between cervical-cancer screenings // N. Engl. J. Med. 2003. — Vol 349. — № 16. — P 1501−1509.
- Sawaya G., Brown A., Washington A. Clinical practice: current approaches to cervical cancer screening // N. Engl. J. Med. 2001. — Vol. 344. — № 21. — P. 1603−1607.
- Sawaya G.F., Grimes D.A. New technologies in cervical cytology screening- a word of caution // Obstet Gynecol. 1999. — Vol. 94. — P. 307−310.
- Schiffman M., Herrero R., Hildeschein A. et al. HPV DNA testing in cervical cancer screening: results from a high-risk province in Costa Rica // JAMA. 2000. — Vol. 283. — P. 87−93.
- Schlecht N. F. Persistent human papillomavirus infection as a predictor of cervical intraepithelial neoplasia // JAMA. 2001. — Vol. 286. P. 3106−3114.
- Schneider A., Hoyer H., Lotz B. et al. Screening for high-grade cervical intra-epithelial neoplasia and cancer by testing for high-risk HPV, routine cytology or colposcopy // Int. .J Cancer. -2000. Vol. 89. — P. 529−534.
- Schneider V., Henry M.R., Jimenez-Ayala M. et al. Cervical cancer screening, screening errors and reporting // Acta Cytol. 2001. — Vol 45. — № 4. — P 493−498.
- Schoell W.M., Janicek M.F., Mirhashemi R. Epidemiology and biology of cervical cancer // Semin. Surg. Oncol. 1999. — Vol. 16. — P. 203 — 211.
- Scully R., Bonfiglio T. WHO classification of tumors of female genital tract // New York. Springer — Verlag. — 1994.
- Sedlacek T.V. Advances in the diagnoses and treatment of human papillomavirus infections // Clin. Obstetr. Gynaec. 1999. — Vol. 42. — № 2. — P. 206−220.
- Selvaggi S.M. Cytologic features of high-grade squamous intraepithelial lesions involving endocervical glands on ThinPrep cytology // Diagn. Cytopathol. 2002. — Vol. 26. — № 3. — P. 181−185.
- Sherlaw-Jonson C., Philips Z. An evaluation of liquid-based cytology and human papillomavirus testing within the UK cervical cancer screening programme // Br J Cancer. 2004. — Vol. 91. — № 1. — P. 84−91.
- Sherman M.E. Baseline cytology, human papillomavirus testing and risk for cervical neoplasia: a 10-year cohort analysis // J. Natl. Cancer Inst. 2003. — Vol. 95.-P. 46−52.
- Sherman M.E., Solomon D., Schiffman M. Qualification of ASCUS: a comparison of equivocal LSIL and equivocal HSIL cervical cytology in ASCUS LSIL. Triage study // Am. J. Clin. Pathol. 2001. — Vol. 116. — P. 386−394.
- Shlay J.C., Dunn Т., Byers T et al. Prediction of cervical intraepithelial neoplasia grade 2−3 using risk assessment and human papillomavirus testing in women with atypia on Papanicolaou smears // Obstet. Gynecol. 2000. — Vol. 96. -P. 410−416.
- Sidawy M., Tabbara S., Silverberg S. Should we report cervical smears lacking endocervical component as unsatisfactory? // Diagn. Cytopathology. -1992.-№ 8.-P. 567−570.
- Smith J.H.F. Bethesda 2001 // Cytopathology. 2002. -№ 13. — P. 4- 10.
- Smith R.A., Cokkinides V., Eyre H. American Cancer Society Guidelines for the early detection of cancer // CA Cancer J. Clinic. 2004. — Vol. 54. — № 1. -P. 41−52.
- Solomon D., Davey D., Kurman R. et al. The 2001 Bethesda system: terminology for reporting results of cervical cytology // JAMA. 2002. — Vol 287. -P. 2114−2119.
- Solomon D., Schiffman M., Tarone R. Comparison of three management strategies for patients with atypical squamous cells of undetermined significance: baseline results from randomized trial // J. Nat. Cancer Inst. 2001. — Vol 93. — № 4-P. 293−299.
- Solomon D., Schiffman M., Tarone R. ASCUS LSIL Triage Study (ALTS) conclusions reaffirmed: response to a November 2001 commentary. 2002. — Vol. 99.-№ 4-P. 671−674.
- Stoler M.H. Human papillomavirus biology and cervical neoplasia: implications for diagnostic criteria and testing // Arch. Pathol. Lab. Med. 2003. -Vol. 127.-P. 935−939.
- Stoler M.H. New Bethesda terminology and evidence-based management guidelines for cervical cytology findings // JAMA. 2002. — Vol. 287. — P. 21 402 141.
- Stoler M.N., Schiffman M. Interobserver reproducibility cervical cytologic and histologic interpretations: realistic estimates from the ASCUS LSIL. Triage study // JAMA. — 2001. — № 285. — P. 1500−1505.
- Survival of Cancer Patients in Europe: Eurocare 2 Study // IARC Science Publ. Lyon. 1999. — № 151.
- Syijanen K.J. Current means to predict disease progression in cervical Carcinogenesis // Cytopathology. 1998. — № 9 — Ad. 1. — P. 5−6.
- Teleman S., Minailovici M.S., Dauciu M., Ferariu D. Cytopathological cervical changes, associated with HPV infection, 27-th European Congress of Cytology // Cytopathology. 2000. — Vol. 11. — № 5. — P. 454.
- Unger E.R., Duarte-Franco E. Human papillomaviruses: into the new millennium // Obstet. Gynecol. Clin. North. Am. 2001. — Vol. 28. — № 4. — P. 653−666.
- US Preventive Services Task Force. Screening for cervical cancer: recommendations and rationale // Am. J. Nurs. 2003. — Vol. 103. — P. 101−109.
- Van Muyden R.C., ter Harmsel B.W., Smedts F.M. et al. Detection and typing of human papillomavirus in cervical carcinomas in Russian women: a prognostic study // Cancer. 1999. — Vol 85. — P. 2011 — 2016.
- Vassilakos P., Carrel S., Petignat P. et al. Use of automated primary screening on liquid-based, thin-layer preparations // Acta Cytol. 2002. — Vol 46. -№ 2. — P 291−295.
- Vassilakos P., Schwartz D., De Marval F. et al. Biopsy-baised comparison of liquid-based thin-layer preparations to conventional Pap smears // J. Reprod. Med. -2000.-Vol. 45.-P. 11−16.
- Visual inspection with acetic acid for cervical cancer screening: test qualities in a primary-care setting. University of Zimbabwe/JHPIEGO Cervical Cancer Project // Lancet. 1999. — Vol. 353. — P. 869−873.
- Walboomers J.M., Jacobs M.V., Manos M.M. et al. Human papillomavirus is necessary cause of invasive cervical cancer worldwide // J. Pathol. 1999. — Vol. 189.-P. 12−19.
- Wang N., Emancipator S.N., Rose P. Histologic follow-up of atypical endocervical cells. Liquid-based, thin-layer preparation vs. conventional Pap smear // Acta Cytol. 2002. — Vol 46. — № 3. — P 453−457.
- Wang-Johanning F., Lu D.W., Wang Y. et al. Quantization of human papillomavirus 16 E6 and E7 DNA and RNA in residual material from ThinPrep
- Papanicolaou tests using real-time polymerase chain reaction analysis // Cancer. -2002. Vol. 94. — № 8. — P. 2199−2210.
- Weiiitraub J., Morabia A. Efficacy of a liquid-based thin layer method for cervical cancer screening in a population with a low incidence of cervical cancer // Diagn. Cytopathol. 2000. — Vol. 22. — № 1 — P. 52−59.
- Wheeler C.E., Yamada Т., Hildesheim A., Jenison S.A. Human papillomavirus type 16 sequence variants: Indication by E6 and LI lineage-specific hybridization // J. Clin. Microbiol.-1997. Vol. 35. — P. 11−19.
- Wilkinson E.J. PAP smears and screening for cervical neoplasia // Clin. Obstet. Gynaecol. 1990. — № 33. — P. 817−825
- Williamson S.L.H., Hair Т., Wadehra V. The effects of different sampling techniques on smear quality and diagnosis of cervical abnormalities in cervical screening // Cytopathology. 1997. — Vol. 8. — P. 188−195.
- Woodman C., Yates M., Ward K. et al. Indicators of effective cytological sampling of the uterine cervix // Lancet. 1989. — № 2. — P. 88−90.
- Woodman C.B., Collin S., Winter H. et al. Natural history of cervical human papillomavirus infection in young women: a longitudinal study // Lancet. — 2001. -Vol. 357.-P. 1831−1836.
- Wright T.C. Cervical cancer screening using visualization techniques. // Journal of the National Cancer Institute Monographs. 2003. — Vol. 31. — P. 66−71.
- Wright T.C., Cox J.T., Massad L.S. 2001 Consensus guidelines for the management of women with cervical cytological abnormalities // JAMA. — 2002. -Vol. 287.-P. 2120−2129.
- Zielinski G.D., Bais A.G., Helmerhorst T.J. et al. HPV testing and monitoring of women after treatment of CIN 3: review of the literature and metaanalysis // Obstet. Gynecol. Surv. 2004. — Vol 59. -№ 7.-P 543−553.
- Zuna R.E., Moore W., Dunn S.T. HPV DNA testing of the residual sample of liquid-based Pap test: utility as a quality assurance monitor // Mod Pathol. — 2001.-Vol. 14. № 3. -P.147−151.
- Zur Hausen H. Papillomaviru^Jai?ctions a major cause of human cancer // Biochim. Biophys. Acta. — 1996. — Vol. 1288. — P. 55−78.